clevidipine

Known as: butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2018
05101519972018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
INTRODUCTION Acute and severe hypertension is common, especially in patients with renal dysfunction (RD). Clevidipine is a… (More)
  • table I
  • figure 1
  • table II
  • table III
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Acute hypertension during cardiac surgery can be difficult to manage and may adversely affect patient outcomes… (More)
Is this relevant?
2008
2008
BACKGROUND Acute postoperative hypertension is a well-known complication of cardiac surgery and is associated with postoperative… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
BACKGROUND Clevidipine is an ultrashort-acting, third-generation IV dihydropyridine calcium channel blocker that exerts rapid and… (More)
Is this relevant?
2003
2003
BACKGROUND AND OBJECTIVE We set out to compare the efficacy of clevidipine and sodium nitroprusside infusions in the control of… (More)
Is this relevant?
2002
2002
BACKGROUND Treatment of elevated blood pressure is frequently necessary after cardiac surgery to minimize postoperative bleeding… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2000
2000
BACKGROUND The aim was to evaluate the use of clevidipine, a new vascular selective, ultra-short-acting calcium antagonist for… (More)
Is this relevant?
1999
1999
Objective: To determine the pharmacokinetics and pharmacodynamics of clevidipine, a new ultrashort-acting calcium antagonist, in… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1999
1999
The objectives of this study were to investigate the protein binding and the in vitro hydrolysis rate of clevidipine and its… (More)
Is this relevant?
1999
1999
AIMS To investigate the tolerability and safety of clevidipine in healthy male volunteers during intravenous infusion at… (More)
Is this relevant?